TRIBALS and patent rights activists have
something to cheer for. In the first
instance of its kind, the Kani tribe
dwelling in the Agastyar hills in
southern Kerala, will get the rights over
an anti-stress drug developed by the
Tropical Botanic Garden and Research
Institute (TBGRI). The tribe had helped
locate the plant from which the drug
was developed.
Under the rights, 50 per cent of
the licence fee and two per cent of
the royalty would go to the tribe.
According to TBGki director, P
Pushpangadan, the drug 'Jeevani'
(Trichopus zey1nicus) had restorative,
immuno-enhancing, anti-stress properties. The tribe's habit of consuming the
leaves of the tiny plant which is known
among them as Arogyapacha (health
drug), was discovered by the scientists
who developed the drug after@ two years
of trial.
For starters, 50 tribal families will be
growing the plant for commercial use.
The TBGRi has transferred the know-how
of the drug to Arya Vaidya Pharmacy,
Coimbatore, which will purchase the
raw material from the tribe, develop the
drug and market it.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
.png)
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.